Security key
05370A108
Atrium Therapeutics, Inc. - Common Stock (RNAM)
CUSIP: 05370A108
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 150,858,761
- Total 13F shares
- 34,505,931
- Share change
- +644,894
- Total reported value
- $852,616,782
- Price per share
- $24.71
- Number of holders
- 93
- Value change
- +$16,849,564
- Number of buys
- 37
- Number of sells
- 45
Report period
Q2 2021
Institutions
93
Top holders
10
Broader feeds
Reporting periods
Holder history for CUSIP 05370A108
Recent filing periods:
Top shareholders of RNAM - Atrium Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Atrium Therapeutics, Inc. - Common Stock (RNAM) as of Q2 2021
As of 30 Jun 2021,
Atrium Therapeutics, Inc. - Common Stock (RNAM) was held by
93 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,505,931 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, FMR LLC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, Cormorant Asset Management, LP, EcoR1 Capital, LLC, FEDERATED HERMES, INC., STATE STREET CORP, VANGUARD GROUP INC, and Matrix Capital Management Company, LP.
This page lists
93
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
97
Q2 2021 holders
93
Holder diff
-4
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.